Jeff Szekeres

Andelyn Biosciences is a full-service cell and gene therapy company that specializes in the development, characterization, and production of viral vectors for gene therapy. The private company is based in Columbus, OH. The company operates out of three facilities in Ohio and offers support to its clients in developing curative cell and gene therapies from concept through plasmid development and manufacturing, process development, and cgmp clinical and commercial manufacturing. Andelyn's advanced digital model, quality system, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of its clients' innovative cell and gene therapies. The company has more than 20 years of experience and has produced cgmp material for over 450 clinical batches and 75 clinical trials. Andelyn's versatile capabilities include cgmp manufacturing capacity for both adherent and suspension processes up to a 2,000-liter capacity. The CEO of the company is Wade Macedone.

Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques.

Eurofins Genomics Blue Heron LLC engages in the development of accurate gene synthesis platform for the production of genes and gene variants for use in expression analysis. Its services include GeneMaker technology, vector synthesis & custom cloning, plasmid preparation, and variant library. The company was founded by John Mulligan in 1999 and is headquartered in Bothell, WA.